PI
MED icon

Putnam Investments’s Medifast MED Stock Holding History

Putnam Investments’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,451
Closed -$358K – 1186
2023
Q1 		$358K Buy
3,451
+209
+6% +$23.2K ﹤0.01% 1034
2022
Q4 		$374K Buy
3,242
+348
+12% +$40.5K ﹤0.01% 1017
2022
Q3 		$314K Buy
2,894
+596
+26% +$85.4K ﹤0.01% 1066
2022
Q2 		$415K Sell
2,298
-24
-1% -$4.29K ﹤0.01% 982
2022
Q1 		$397K Sell
2,322
-165
-7% -$31.1K ﹤0.01% 1082
2021
Q4 		$521K Buy
+2,487
New +$514K ﹤0.01% 993

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Putnam Investments's MED Position: Q2 2023 in Review

Putnam Investments sold out of Medifast (MED) in Q2 2023, closing a stake of 3,451 shares — an estimated $358K sold.

Putnam Investments first reported a position in MED in Q4 2021 and held it in 6 quarters. The position peaked at $521K in Q4 2021. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • Putnam Investments reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • Putnam Investments sold 3,451 Medifast shares in Q2 2023, an estimated $358K.
  • Putnam Investments first reported a position in Medifast in Q4 2021 and held it in 6 quarters.
  • Putnam Investments's Medifast position peaked at $521K in Q4 2021.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Putnam Investments's 13F filing for Q2 2023, filed 14 Aug 2023.